University of Kansas Medical Center: Breakthrough Cystic Fibrosis Drug Poised to Benefit More People With CF
August 26, 2021
August 26, 2021
KANSAS CITY, Kansas, Aug. 26 (TNSJou) -- The University of Kansas Medical Center issued the following news:
Since the U.S. Food and Drug Administration approved a breakthrough drug for cystic fibrosis (CF) in 2019, the media has been full of joyful, moving stories about its wondrous effect on the lives of individual patients.
A man who had been trying to raise money for a lung transplant experienced a massive clearing of his lungs within just one day of his first dose. . . .
Since the U.S. Food and Drug Administration approved a breakthrough drug for cystic fibrosis (CF) in 2019, the media has been full of joyful, moving stories about its wondrous effect on the lives of individual patients.
A man who had been trying to raise money for a lung transplant experienced a massive clearing of his lungs within just one day of his first dose. . . .